- Home
- MNY vs COEP Comparison
MNY vs COEP Comparison
Compare MNY & COEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNY
- COEP
- Stock Information
- Founded
- MNY 2014
- COEP 2017
- Country
- MNY Singapore
- COEP United States
- Employees
- MNY N/A
- COEP N/A
- Industry
- MNY
- COEP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MNY
- COEP Health Care
- Exchange
- MNY Nasdaq
- COEP Nasdaq
- Market Cap
- MNY 31.9M
- COEP 27.4M
- IPO Year
- MNY N/A
- COEP N/A
- Fundamental
- Price
- MNY $1.50
- COEP $11.26
- Analyst Decision
- MNY Strong Buy
- COEP
- Analyst Count
- MNY 1
- COEP 0
- Target Price
- MNY $4.00
- COEP N/A
- AVG Volume (30 Days)
- MNY 517.5K
- COEP 38.9K
- Earning Date
- MNY 06-13-2025
- COEP 08-15-2025
- Dividend Yield
- MNY N/A
- COEP N/A
- EPS Growth
- MNY N/A
- COEP N/A
- EPS
- MNY N/A
- COEP N/A
- Revenue
- MNY $71,649,746.00
- COEP $62,874.00
- Revenue This Year
- MNY $16.97
- COEP N/A
- Revenue Next Year
- MNY $19.35
- COEP N/A
- P/E Ratio
- MNY N/A
- COEP N/A
- Revenue Growth
- MNY N/A
- COEP N/A
- 52 Week Low
- MNY $0.55
- COEP $2.31
- 52 Week High
- MNY $1.88
- COEP $13.70
- Technical
- Relative Strength Index (RSI)
- MNY 75.86
- COEP 74.07
- Support Level
- MNY $0.99
- COEP $7.25
- Resistance Level
- MNY $1.10
- COEP $10.00
- Average True Range (ATR)
- MNY 0.18
- COEP 0.66
- MACD
- MNY 0.06
- COEP 0.36
- Stochastic Oscillator
- MNY 68.85
- COEP 90.20
About MNY MoneyHero Limited
MoneyHero Ltd is a personal finance aggregation and comparison company in Greater Southeast Asia. The firm is involved in the operation of online financial comparison platforms and related services for credit cards, personal loans, mortgages, insurance, and other financial products, connecting the providers of these products with well-matched and ready-to-transact consumers and generating revenue directly from these providers for placing their products on its platforms and providing insurance brokerage, marketing and events-related services. Geographically it operates in Singapore, Hong Kong, Taiwan, Malaysia and the Philippines.
About COEP Coeptis Therapeutics Holdings Inc.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.